Epista Life Science is proud to announce our recognition as a Sample Vendor for Compliant GxP Cloud Services in both the Gartner Hype Cycle for Life Science Research and Development, 2020 (1) and the Gartner Hype Cycle for Life Science Manufacturing, Quality and Supply Chain, 2020 (2).
According to the Compliant GxP Cloud Services category in the Hype Cycle reports, Gartner suggests the following business impact area: “Adopting a GxP cloud service strategy can augment IT groups and organizations that lack their own validation capabilities. The costs and benefits, driven chiefly by automation, are particularly significant for small and midsize businesses that may lack the expertise, resources, and infrastructure to maintain these environments. Larger enterprises also will benefit, but principally through flexibility rather than direct cost reduction. In the near term, the benefits will be driven primarily through rapid provisioning that requires minimal manual intervention. Over the longer term, more system management tasks will be automated, leading to more efficient infrastructure management.”
Klavs Esbjerg, CEO of Epista, states: “We are honored by this recognition from Gartner. We’ve been saying it for a long time: Once your system is live, well-tuned and supports your business goals - where do you go from there? Do you have specialists in your company to maintain system operations? It's more than keeping the system in a validated state through frequent patches and upgrades. The system must stay well-tuned, so it works for your users and supports your business KPIs - not the other way around. Is this the most efficient way to use your internal resources? Whatever IT systems you're using, our subject-matter-experts have the experience you need to support your systems with managed operations, efficiently.”
If you’re ready to move to the Cloud, we’re ready to help. Read more about the proven path to your future platform with Epista’s Pharma Cloud Transition solution.
1. Gartner, “Hype Cycle for Life Science Research and Development, 2020,” by Jeff Smith and Michael Shanler, 13 August 2020
2. Gartner, “Hype Cycle for Life Science Manufacturing, Quality and Supply Chain, 2020,” by Michael Shanler, Stephen Meyer and Andrew Stephens, 12 August 2020
Gartner does not endorse any vendor, product, or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Garter research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
We enjoy sharing our knowledge. Get in touch to find out how Epista can add value to your Life Science company.